Evidence map›Paper›PMID 30110373›Full record

ArticlePloS one2018

Twenty-seven year surveillance of blood transfusion recipients infected with HIV-1 in Hebei Province, China.

Suliang Chen, Xinli Lu, Guangyi Bai, Yuqi Zhang, Baojun Li, Wei Wang, Liang Liang, Lin Ma, Yan Li, Xiaofeng Wang and 3 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Suliang ChenHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Xinli LuHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.ORCID 0000-0003-4613-2028
Guangyi BaiHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Yuqi ZhangHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Baojun LiHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Wei WangHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Liang LiangHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Lin MaHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Yan LiHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Xiaofeng WangHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Yingying WangHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Cuiying ZhaoHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.
Hongru ZhaoHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted an investigation of blood management in which blood transfusion recipients underwent molecular biological analysis, to trace the possible source of HIV infection. Epidemiological investigation was carried out among HIV-infected individuals. Blood transfusion recipients infected with HIV were tracked for the date of transfusion, reason for transfusion, hospital where transfusion was received, source of blood, components of transfusion, number of transfusions, and transfusion volume. A total of 285 blood transfusion recipients infected with HIV-1 were detected in Hebei over the study period, with 42.81% (122/285) detected through clinical diagnostic testing. These cases showed a concentrated distribution in southern Hebei, with local outbreak characteristics. A census of the population in Shahe County, which had a high concentration of cases, revealed that recipients of blood transfusions had an HIV infection rate of 15.54% (92/592). Post-transfusion infection frequently occurred among blood transfusion recipients at township medical institutions, with a peak in 1995. Owing to late detection of HIV infection among blood transfusion recipients, the rates of spousal transmission and mother-to-child transmission reached 20.87% and 28.05%, respectively. Around 1995, community medical institutions did not screen for HIV antibodies among paid blood donors, which was an important cause of the outbreak of HIV-1 infection among blood transfusion recipients. Our findings indicate that cases of blood transfusion-related infection decreased rapidly with gradual improvement in the HIV screening system for blood donors that began in 1995, particularly after full implementation of HIV nucleic acid testing of volunteer blood donors was begun in 2015.

Indexed as

Blood TransfusionHIV-1Transfusion ReactionAdolescentAdultBlood DonorsChildChild, PreschoolChinaDisease OutbreaksEpidemiological MonitoringFemaleHIV AntibodiesHIV InfectionsHumansInfantHIV Antibodies

Identifiers

PMID30110373
PMCPMC6093692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.